AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $85.25
- 52-wk low
- $48.20
- Prev close
- $72.52
- Mkt cap
- $3.22B
- Fwd P/E
- 106.4x
- Beta
- 0.51
Smart money
Earnings
Earnings came in 104.8% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $118.7M | $151.7M | $162.1M | $173.9M |
| Cost of what it sold | $24.6M | $10.9M | $9.4M | $12.1M |
| Gross profit | $94.1M | $140.7M | $152.7M | $161.8M |
| What it spent | ||||
| Research and development | $16.3M | $18.0M | $22.4M | $31.0M |
| Sales and admin | $108.6M | $130.7M | $136.4M | $150.7M |
| Other operating costs | -$16.3M | — | — | — |
| Total operating expenses | $108.6M | $148.7M | $158.8M | $181.7M |
| What was left | ||||
| Operating profit | -$14.5M | -$8.0M | -$6.1M | -$19.9M |
| Interest on debt | $2.1M | $2.2M | $2.1M | $2.2M |
| Profit before tax | -$12.6M | -$6.3M | -$9.3M | -$15.8M |
| Tax | — | $2.1M | -$2.4M | $2.7M |
| Net profit | -$12.6M | -$8.4M | -$7.0M | -$18.6M |
| EBITDA | -$12.1M | -$3.7M | -$6.8M | -$12.7M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
32 articles · 7 days
Coverage is bullish
Tone of tracked coverage
TimesSquare Capital Management LLC Takes $23.25 Million Position in Tarsus Pharmaceuticals, Inc. $TARS
Leans bullishAug 18Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?
Leans bullishAug 18Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next
Bullish